TSE:NWH.UN

Northwest Health Prop Real Est Inv Trust (NWH.UN.TO)

5.66
-0.01 (0.18%)
as of Mar 10, 2026, 8:00:00 pm Market Open.
343 watching
0
Investor Insights
star iconJun 24, 2026, 12:00 am

This summary was created by AI, based on 10 opinions in the last 12 months.

Northwest Health Prop Real Est Inv Trust (NWH.UN-T) has been undergoing significant transformation under new management, particularly a CEO with experience from Brookfield. The company is in a restructuring phase, focusing on its North American assets while divesting from international operations, which many analysts view as a necessary step due to previous over-leverage. Despite challenges, including increased debt servicing costs and a forced asset sale, the company appears to have stabilized operations. Analysts note a stable yield over 6%, with some optimism surrounding its long-term potential, although many express caution regarding immediate price appreciation. Overall, the company's diverse portfolio of medical assets presents opportunity, but future growth may hinge on its execution of strategic initiatives.

consensus icon
Consensus
Cautious
valuation icon
Valuation
Undervalued
review icon
Similar
CNA, CEC
TOP PICK

The only REIT he owns. The property portfolio is not just Canadian but half is international. The CEO is a very smart capital allocator. He owns quite a bit of the company. (Analysts’ target: $11.65).

DON'T BUY

He long ago owned this. It trades at a cheap 14x AFFO. It's in several businesses across several georgapies (i.e. German, Australia, Canada). But he wants a REIT that's highly specific or is best in class. This is neither. Their last quarter was weak, too. They'll need a lot of acqusitions to keep going. They're stretched out.

COMMENT

Their plan is to acquire medical office buildings and standardize the rent and leases, get advertising and get parking. It was a Canadian only entity, but then merged with Northwest International, and has become a much bigger REIT. A REIT is fine in your portfolio, but it’s hard to get excited about a company that has to pay out 95% of its cash flow to shareholders. The valuation on all REITs is quite expensive at this time. Yield of almost 7%.

COMMENT

A really interesting organization. You are buying healthcare assets, such as hospitals and medical treatment centres in multiple markets such as Brazil, Germany, New Zealand and Canada. That really diversifies your risk. He doesn’t own it because as a real estate guy he has trouble valuing properties in those kind of diverse markets, without really understanding what is happening in healthcare, etc. 7.3% dividend yield.

COMMENT

A globally diversified REIT with exposure in Canada, Brazil, Germany, Austria and Asia. Rather than being in healthcare, they are more of a rent collector. In Canada, in particular, they run medical office buildings, which is a more defensive part of the market. Yield of about 8%. Although it has some positive attributes, the balance sheet is stretched, and a lot of their debts are in convertible bonds.

COMMENT

This has medical office buildings in other parts of the world like Brazil, Australia, New Zealand. There are a lot of cross currency issues. Has a relatively high payout ratio. He prefers other names in terms of risk/reward.

SHORT

NWH.UN-T vs. CSH.UN-T. CSH.UN-T has decent growth because of their demographics. His problem with REITs is that they were one of the biggest beneficiaries of the low interest rate. He looks at the cap rate and turns it into an enterprise value and you are paying 15-16 times operating cash flow. You should pay that for a high tech company, not a healthcare company. You are paying out 80-90% of the income as yield. You can’t do that in other sectors. Where is the money to invest in the business – how does it grow? He went short the REITs about two months ago. He does not like either one, but if forced to choose it would be CSH.UN-T.

COMMENT

Something of a healthcare REIT, and is typical of a lot of younger REITs where they’ve got a development company that identifies properties, builds them up and gets them fully leased, and blends them in. This has had some hiccups in the last little while. It is trading at a discount to NAV. Not a bad way to play the sector if you are looking for real estate exposure in this particular area.

COMMENT

(Market Call Minute.) Excellent management. A niche business in that they are growing in the healthcare space but have now focused outside of Canada, and are getting leased properties that have cap rates that you don’t really see in Canada. Being in a foreign market, currency is an obvious issue. If you own it, he expects you are going to get a nice distribution. Expect they will make acquisitions and grow.

COMMENT

Has trouble figuring out the Brazilian, German, New Zealand and Canadian Healthcare systems, so doesn’t own this. Because it is so complex, he thinks it should trade at a higher yield. Going forward they are committed to growth from a global standpoint. He’ll wait for a couple of more quarters and look for a more stable growth trend.

COMMENT

Owns this in his income portfolio. Their portfolio is diversified outside of Canada. Thinks they will continue to grow by acquisition. They pay nice yield and the CEO owns a fair bit of the stock as well.

COMMENT

(Market Call Minute.) Global exposure to different healthcare sectors, Australia, Germany and Brazil. A little too complicated.

WAIT

When you buy this, you are getting the core Medical Office Buildings in Canada, which leases to doctors and clinics. You are also getting some assets in Germany, New Zealand and Brazil. (Hospital type assets.) Have recently gone through a merger and restructuring. He’d like to give it a couple of quarters of hard data to see how they do.

COMMENT

The largest owner of medical office buildings in Canada with some exposure in Brazil, New Zealand and Germany. Because it is so diverse it is tough for investors to get a handle on what is happening in each of those different markets, especially if you consider what is going on in Brazil. He has some underlying concerns about the health in some of those markets. Has a relatively high payout ratio that is going to have to rely on acquisitions to facilitate growth. In this market, where most REITs are trading at a substantial discount to NAV, it is going to be much harder to realize non-organic growth. Prefers others.

BUY

Their recent merger with North West International has changed the properties dramatically. They have medical buildings and hospitals in Brazil, Australia and Germany now. The portfolio has held up well in Brazil, but he worries about the currency risk. The balance sheet is in excellent shape. He thinks the prospects are excellent.

Showing 61 to 75 of 133 entries